Publication:
Tramadol: A valuable treatment for pain in Southeast Asian countries

dc.contributor.authorRamani Vijayanen_US
dc.contributor.authorGauhar Afshanen_US
dc.contributor.authorKhalid Bashiren_US
dc.contributor.authorMary Cardosaen_US
dc.contributor.authorMadhur Chadhaen_US
dc.contributor.authorPongparadee Chaudakshetrinen_US
dc.contributor.authorKhin Myo Hlaen_US
dc.contributor.authorMuralidhar Joshien_US
dc.contributor.authorFrancis O. Javieren_US
dc.contributor.authorAsif Gul Kayanien_US
dc.contributor.authorAndi Takdir Musbaen_US
dc.contributor.authorSasikaan Nimmaanraten_US
dc.contributor.authorDwi Pantjawibowoen_US
dc.contributor.authorJocelyn C. Queen_US
dc.contributor.authorPalanisamy Vijayananden_US
dc.contributor.otherDe La Salle Health Sciences Instituteen_US
dc.contributor.otherYangon General Hospitalen_US
dc.contributor.otherUniversity of Santo Tomas, Manilaen_US
dc.contributor.otherHasanuddin Universityen_US
dc.contributor.otherThe Aga Khan Universityen_US
dc.contributor.otherUniversity of Malaya Medical Centreen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherPrince of Songkla Universityen_US
dc.contributor.otherKulsum International Hospitalen_US
dc.contributor.otherPrimus Hospital and Fortis Group of Hospitalsen_US
dc.contributor.otherHameed Latif Hospitalen_US
dc.contributor.otherRamsay Premier Bintaro Hospitalen_US
dc.contributor.otherVirinchi Hospitalsen_US
dc.contributor.otherSri Ramakrishna Hospitalen_US
dc.contributor.otherHospital Selayangen_US
dc.date.accessioned2019-08-28T06:40:41Z
dc.date.available2019-08-28T06:40:41Z
dc.date.issued2018-01-01en_US
dc.description.abstract© 2018 Vijayan et al. Background: The supply of controlled drugs is limited in the Far East, despite the prevalence of health disorders that warrant their prescription. Reasons for this include strict regulatory frameworks, limited financial resources, lack of appropriate training amongst the medical profession and fear of addiction in both general practitioners and the wider population. Consequently, the weak opioid tramadol has become the analgesic most frequently used in the region to treat moderate to severe pain. Methods: To obtain a clearer picture of the current role and clinical use of tramadol in Southeast Asia, pain specialists from 7 countries in the region were invited to participate in a survey, using a questionnaire to gather information about their individual use and experience of this analgesic. Results: Fifteen completed questionnaires were returned and the responses analyzed. Tramadol is used to manage acute and chronic pain caused by a wide range of conditions. Almost all the specialists treat moderate cancer pain with tramadol, and every one considers it to be significant or highly significant in the treatment of moderate to severe non-cancer pain. The reasons for choosing tramadol include efficacy, safety and tolerability, ready availability, reasonable cost, multiple formulations and patient compliance. Its safety profile makes tramadol particularly appropriate for use in elderly patients, outpatients, and for long-term treatment. The respondents strongly agreed that tighter regulation of tramadol would reduce its medical availability and adversely affect the quality of pain management. In some countries, there would no longer be any appropriate medication for cancer pain or the long-term treatment of chronic pain. Conclusions: In Southeast Asia, tramadol plays an important part in the pharmacological management of moderate to severe pain, and may be the only available treatment option. If it were to become a controlled substance, the standard of pain management in the region would decline.en_US
dc.identifier.citationJournal of Pain Research. Vol.11, (2018), 2567-2575en_US
dc.identifier.doi10.2147/JPR.S162296en_US
dc.identifier.issn11787090en_US
dc.identifier.other2-s2.0-85058775654en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/47250
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058775654&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTramadol: A valuable treatment for pain in Southeast Asian countriesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058775654&origin=inwarden_US

Files

Collections